Patent: 7,514,252
✉ Email this page to a colleague
Summary for Patent: 7,514,252
| Title: | Cell-specific and/or tumor-specific promoter retargeting of herpes .gamma. 34.5 gene expression |
| Abstract: | The present invention relates to herpes viral mutants and methods of using these viral mutants for selectively targeting tumor cells or other populations of target cells. The viral mutants of the invention are capable of selective targeting due to the use of tumor-specific and/or cell-specific promoters to drive expression of the herpes .gamma.34.5 gene. |
| Inventor(s): | Chiocca; E. Antonio (Powell, OH), Chung; Richard Y. (Boston, MA) |
| Assignee: | The General Hospital Corporation (Boston, MA) |
| Application Number: | 11/042,189 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,514,252
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2019-08-31 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
